{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:54:51Z","timestamp":1791996891600,"version":"4.4.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jconrel.2021.04.008","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T18:55:45Z","timestamp":1618599345000},"page":"560-578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Challenges and strategies for the delivery of biologics to the cornea"],"prefix":"10.1016","volume":"333","author":[{"given":"M.","family":"Wels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Raemdonck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"De Smedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sauvage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.04.008_bb0005","author":"WHO"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0010","first-page":"571","article-title":"Diagnosis and management of neurotrophic keratitis","volume":"8","author":"Sacchetti","year":"2014","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0015","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000779","article-title":"Experimental modeling of cornea wound healing in diabetes: clinical applications and beyond","volume":"7","author":"Bu","year":"2019","journal-title":"BMJ Open Diabetes Res. Care"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0020","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/0264619610374171","article-title":"Emotional well-being in people with sight loss","volume":"28","author":"Nyman","year":"2010","journal-title":"Br. J. Vis. Impair."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ophtha.2019.08.033","article-title":"Child vision patient-reported outcome measures group, an age- and stage-appropriate patient-reported outcome measure of vision-related quality of life of children and young people with visual impairment","volume":"127","author":"Tadi\u0107","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0030","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1001\/jamaophthalmol.2015.4776","article-title":"Global survey of corneal transplantation and eye banking","volume":"134","author":"Gain","year":"2016","journal-title":"JAMA Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0035","first-page":"1154","article-title":"Corneal blindness and current major treatment concern-graft scarcity","volume":"10","author":"Wong","year":"2017","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0040","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.medengphy.2019.05.002","article-title":"3D bioprinting for artificial cornea: challenges and perspectives","volume":"71","author":"Zhang","year":"2019","journal-title":"Med. Eng. Phys."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/aes.2018.01.01","article-title":"The development of tissue engineering corneal scaffold: which one the history will choose?","volume":"3","author":"Lin","year":"2018","journal-title":"Ann. Eye Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrd.2018.183","article-title":"Non-invasive delivery strategies for biologics","volume":"18","author":"Anselmo","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"Suppl. 2","key":"10.1016\/j.jconrel.2021.04.008_bb0055","first-page":"S1","article-title":"The IC3D classification of the corneal dystrophies","volume":"27","author":"Weiss","year":"2008","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2015.12.008","article-title":"A COL17A1 splice-altering mutation is prevalent in inherited recurrent corneal erosions","volume":"123","author":"Oliver","year":"2016","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0065","doi-asserted-by":"crossref","DOI":"10.1097\/01.ico.0000178743.06340.2c","article-title":"How the cornea heals: cornea-specific repair mechanisms affecting surgical outcomes","volume":"24","author":"Fini","year":"2005","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0070","doi-asserted-by":"crossref","DOI":"10.1111\/j.1755-3768.2019.8248","article-title":"Corneal transparency restoration by gene therapy","volume":"97","author":"Mohan","year":"2019","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0075","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jtos.2017.03.006","article-title":"TFOS DEWS II tear film report","volume":"15","author":"Willcox","year":"2017","journal-title":"Ocul. Surf."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0080","first-page":"264","article-title":"Determination of tear volume and tear flow","volume":"5","author":"Mishima","year":"1966","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0085","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/jop.1987.3.159","article-title":"Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbit: implications in the design of strategies to maximize the ratio of ocular to systemic absorption","volume":"3","author":"Chang","year":"1987","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0090","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1023\/A:1018938310628","article-title":"Controlled ocular timolol delivery: systemic absorption and intraocular pressure effects in humans","volume":"11","author":"Urtti","year":"1994","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0095","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.bbamem.2016.02.020","article-title":"Tear film lipid layer: a molecular level view","volume":"1858","author":"Cwiklik","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0100","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.3389\/fphar.2019.01560","article-title":"Albumin levels in tear film modulate the bioavailability of medically-relevant topical drugs","volume":"10","author":"Sebbag","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0105","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0039-6257(81)90145-4","article-title":"Clinical biochemistry of tears","volume":"26","author":"Van Haeringen","year":"1981","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0110","first-page":"4080","article-title":"C57BL\/6 mice lacking Muc1 show no ocular surface phenotype","volume":"41","author":"Danjo","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0115","first-page":"1328","article-title":"Bacterial conjunctivitis in Muc1 null mice","volume":"40","author":"Kardon","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0120","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1167\/iovs.07-0430","article-title":"Functions of MUC16 in corneal epithelial cells","volume":"48","author":"Blalock","year":"2007","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1167\/iovs.05-0735","article-title":"Mucin characteristics of human corneal-limbal epithelial cells that exclude the rose bengal anionic dye","volume":"47","author":"Arg\u00fceso","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0130","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/ACI.0b013e32830e6b04","article-title":"Functions of ocular surface mucins in health and disease","volume":"8","author":"Mantelli","year":"2008","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0135","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejpb.2015.02.032","article-title":"Undefined role of mucus as a barrier in ocular drug delivery","volume":"96","author":"Ruponen","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0140","doi-asserted-by":"crossref","DOI":"10.1089\/jop.2020.0022","article-title":"Mucus-penetrating particles and the role of ocular mucus as a barrier to micro- and nanosuspensions","author":"Popov","year":"2020","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0145","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijpharm.2017.09.018","article-title":"Physicochemical properties of mucus and their impact on transmucosal drug delivery","volume":"532","author":"Leal","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0150","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1089\/jop.2018.0059","article-title":"Effect of Mucoadhesive polymeric formulation on corneal permeation of Fluoroquinolones","volume":"34","author":"Gade","year":"2018","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0155","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ejpb.2009.02.006","article-title":"Bioadhesive sulfacetamide sodium microspheres: evaluation of their effectiveness in the treatment of bacterial keratitis caused by Staphylococcus aureus and Pseudomonas aeruginosa in a rabbit model","volume":"72","author":"Sensoy","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ijpharm.2012.04.060","article-title":"Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies","volume":"432","author":"Bhatta","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0165","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.3109\/03639045.2015.1066798","article-title":"Mucoadhesive nano-sized supramolecular assemblies for improved pre-corneal drug residence time","volume":"41","author":"Fabiano","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0170","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0175","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1242\/jcs.198119","article-title":"Corneal epithelial stem cells and their niche at a glance","volume":"130","author":"Nowell","year":"2017","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0180","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0185","first-page":"627","article-title":"Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera","volume":"38","author":"K.M. Association for Research in Vision and Ophthalmology","year":"1997","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0190","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.addr.2006.07.024","article-title":"Drug transport in corneal epithelium and blood\u2013retina barrier: emerging role of transporters in ocular pharmacokinetics","volume":"58","author":"Mannermaa","year":"2006","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/0378-5173(92)90308-O","article-title":"The effect of drug charge type and charge density on corneal transport","volume":"88","author":"Liaw","year":"1992","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0200","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00003226-200007000-00001","article-title":"Bowman\u2019s layer structure and function: critical or dispensable to corneal function? A hypothesis","volume":"19","author":"Wilson","year":"2000","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0205","series-title":"Drug Deliv","first-page":"63","article-title":"Thin-film materials","author":"Holowka","year":"2014"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0210","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/02713688609015099","article-title":"Immunohistochemical characterization of extracellular matrix in the developing human cornea","volume":"5","author":"Ben-Zvi","year":"1986","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0215","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1083\/jcb.106.3.999","article-title":"Collagen type I and type V are present in the same fibril in the avian corneal stroma","volume":"106","author":"Birk","year":"1988","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0220","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1021\/js9802594","article-title":"Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye","volume":"87","author":"Prausnitz","year":"1998","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0225","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-4835(83)90157-4","article-title":"Identification of collagens isolated from bovine Descemet\u2019s membrane","volume":"37","author":"Labermeier","year":"1983","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0230","first-page":"2680","article-title":"Distribution of collagen IV in human ocular tissues","volume":"34","author":"Ishizaki","year":"1993","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jsb.2009.03.012","article-title":"Determining the mechanical properties of human corneal basement membranes with atomic force microscopy","volume":"167","author":"Last","year":"2009","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0240","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1002\/jcp.24077","article-title":"Facilitated diffusion of VEGF165 through descemet\u2019s membrane with sucrose octasulfate","volume":"227","author":"Fannon","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0245","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1038\/s41598-018-22821-9","article-title":"TGF-\u03b21 promotes cell barrier function upon maturation of corneal endothelial cells","volume":"8","author":"Beaulieu Leclerc","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0250","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1167\/iovs.05-0745","article-title":"Antibody blockade of Junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling","volume":"47","author":"Mandell","year":"2006","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0255","doi-asserted-by":"crossref","first-page":"971","DOI":"10.3389\/fphar.2018.00971","article-title":"Non-viral delivery of nucleic acids: insight into mechanisms of overcoming intracellular barriers","volume":"9","author":"Durymanov","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0260","doi-asserted-by":"crossref","first-page":"R72","DOI":"10.1186\/gb-2006-7-8-r72","article-title":"Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors","volume":"7","author":"de Souza","year":"2006","journal-title":"Genome Biol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0265","first-page":"180","article-title":"Tear lipocalin is the major endonuclease in tears","volume":"14","author":"Yusifov","year":"2008","journal-title":"Mol. Vis."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0270","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrg3763","article-title":"Non-viral vectors for gene-based therapy","volume":"15","author":"Yin","year":"2014","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0275","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1016\/j.ophtha.2014.03.038","article-title":"Aganirsen antisense oligonucleotide eye drops inhibit keratitis-induced corneal neovascularization and reduce need for transplantation: the I-CAN study","volume":"121","author":"Cursiefen","year":"2014","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0280","doi-asserted-by":"crossref","first-page":"6447","DOI":"10.1167\/iovs.16-20303","article-title":"Safety and efficacy clinical trials for SYL1001, a novel short interfering RNA for the treatment of dry eye disease","volume":"57","author":"Benitez-Del-Castillo","year":"2016","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0285","first-page":"102","article-title":"Tivanisiran as a new treatment for dry eye in patients with Sj\u00f6gren syndrome","volume":"61","author":"Gonzalez","year":"2020","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0290","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3762\/bjnano.11.10","article-title":"Internalization mechanisms of cell-penetrating peptides","volume":"11","author":"Ruseska","year":"2020","journal-title":"Beilstein J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0295","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/sj.mt.6300324","article-title":"Cell-penetrating peptide for enhanced delivery of nucleic acids and drugs to ocular tissues including retina and cornea","volume":"16","author":"Johnson","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0300","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.visres.2009.08.028","article-title":"Cell penetrating peptide POD mediates delivery of recombinant proteins to retina, cornea and skin","volume":"50","author":"Johnson","year":"2010","journal-title":"Vis. Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0305","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jconrel.2017.11.019","article-title":"Repurposing cationic amphiphilic drugs as adjuvants to induce lysosomal siRNA escape in nanogel transfected cells","volume":"269","author":"Joris","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0310","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1021\/acsnano.0c00666","article-title":"Cationic amphiphilic drugs boost the lysosomal escape of small nucleic acid therapeutics in a nanocarrier-dependent manner","volume":"14","author":"Van de Vyver","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0315","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.nantod.2017.06.012","article-title":"Small molecules convey big messages: boosting non-viral nucleic acid delivery with low molecular weight drugs","volume":"16","author":"Joris","year":"2017","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0320","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.omtn.2019.07.017","article-title":"Effective in vivo topical delivery of siRNA and gene silencing in intact corneal epithelium using a modified cell-penetrating peptide","volume":"17","author":"Schiroli","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0325","first-page":"415","article-title":"Chloroquine ocular toxicity","volume":"12","author":"Bernstein","year":"1967","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0330","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s13346-018-0546-0","article-title":"Corneal chemical burn treatment through a delivery system consisting of TGF-\u03b21 siRNA: in vitro and in vivo","volume":"8","author":"Zahir-Jouzdani","year":"2018","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0335","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2174\/1874364101004010052","article-title":"Aqueous humor dynamics: a review","volume":"4","author":"Goel","year":"2010","journal-title":"Open Ophthalmol. J."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0340","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/B978-0-323-46143-6.00014-2","article-title":"Polymer-based nanocarriers for therapeutic nucleic acids delivery","author":"Yuan","year":"2017","journal-title":"Nanostruct. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0345","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2020.07.004","article-title":"Topical siRNA delivery to the cornea and anterior eye by hybrid silicon-lipid nanoparticles","volume":"326","author":"Baran-Rachwalska","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0350","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/bjp.2008.349","article-title":"Viral vectors: from virology to transgene expression","volume":"157","author":"Bouard","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0355","author":"US Food and Drug Administration"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0360","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s40265-019-01162-5","article-title":"Onasemnogene Abeparvovec: First Global Approval","volume":"79","author":"Hoy","year":"2019","journal-title":"Drugs."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0365","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2147\/TACG.S178546","article-title":"gene therapy for beta-thalassemia: updated perspectives","volume":"12","author":"Karponi","year":"2019","journal-title":"Appl. Clin. Genet."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0370","first-page":"22","article-title":"Seeking solutions for large-scale GMP viral vector manufacturing","volume":"43","author":"Challener","year":"2019","journal-title":"Pharm. Technol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0375","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1006\/exer.1998.0557","article-title":"Adenovirus-mediated gene transfer to the ocular surface epithelium","volume":"67","author":"Tsubota","year":"1998","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0380","article-title":"Chitosan modification of adenovirus to modify transfection efficiency in bovine corneal epithelial cells","volume":"5","author":"Wang","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0385","first-page":"1392","article-title":"Herpes simplex virus-mediated gene delivery to the rodent visual system","volume":"41","author":"Spencer","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0390","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/md15120370","article-title":"Chitosan nanoparticles as a mucoadhesive drug delivery system for ocular administration","volume":"15","author":"Silva","year":"2017","journal-title":"Mar. Drugs."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0395","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1089\/jop.2012.0193","article-title":"Mucoadhesive chitosan\u2013dextran sulfate nanoparticles for sustained drug delivery to the ocular surface","volume":"29","author":"Chaiyasan","year":"2013","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112776","article-title":"A critical review of electroporation as a plasmid delivery system in mouse skeletal muscle","volume":"20","author":"Soko\u0142owska","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0405","doi-asserted-by":"crossref","DOI":"10.3390\/molecules23113044","article-title":"A Review on electroporation-based intracellular delivery","volume":"23","author":"Shi","year":"2018","journal-title":"Molecules."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0410","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jgm.231","article-title":"High-level gene transfer to the cornea using electroporation","volume":"4","author":"Blair-Parks","year":"2002","journal-title":"J. Gene Med."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0415","first-page":"362","article-title":"Gene transfer of interleukin 10 to the murine cornea using electroporation","volume":"232","author":"Zhou","year":"2007","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0420","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1046\/j.1365-4362.2000.00925.x","article-title":"The gene gun: current applications in cutaneous gene therapy","volume":"39","author":"Lin","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0425","doi-asserted-by":"crossref","first-page":"484","DOI":"10.2144\/97233st06","article-title":"Controlled gene gun delivery and expression of DNA within the cornea","volume":"23","author":"Tanelian","year":"1997","journal-title":"Biotechniques."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0430","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00417-001-0411-5","article-title":"Minimizing side effects of ballistic gene transfer into the murine corneal epithelium","volume":"240","author":"Zhang","year":"2002","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0435","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00417-005-0070-z","article-title":"Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense","volume":"244","author":"Bauer","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0440","first-page":"2554","article-title":"Identification of the cornea-specific keratin 12 promoter by in vivo particle-mediated gene transfer","volume":"39","author":"Shiraishi","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0445","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1001\/archopht.124.11.1620","article-title":"Regulation of corneal repair by particle-mediated gene transfer of opioid growth factor receptor complementary DNA","volume":"124","author":"Zagon","year":"2006","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0450","article-title":"Particle-mediated administration of plasmid DNA on corneas of BALB\/c mice","volume":"940","author":"D","year":"2013","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0455","series-title":"Gene Delivery, An Introd. to Biotechnol","first-page":"275","author":"Godbey","year":"2014"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0460","first-page":"182","article-title":"Clinical correlates of common corneal neovascular diseases: a literature review","volume":"8","author":"Abdelfattah","year":"2015","journal-title":"Int. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0465","first-page":"2514","article-title":"Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas","volume":"41","author":"Philipp","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0470","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/02713681003597230","article-title":"A SiRNA targeting vascular endothelial growth factor-a inhibiting experimental corneal neovascularization","volume":"35","author":"Zuo","year":"2010","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0475","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/ICO.0b013e31802b4201","article-title":"Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization","volume":"26","author":"Singh","year":"2007","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0480","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/S0002-9440(10)63267-1","article-title":"Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis","volume":"165","author":"Kim","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0485","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/jac\/dks379","article-title":"The enhanced permeability retention effect: a new paradigm for drug targeting in infection","volume":"68","author":"Azzopardi","year":"2013","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0490","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0495","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1517\/17425247.3.3.445","article-title":"ICS-283: a system for targeted intravenous delivery of siRNA","volume":"3","author":"Schiffelers","year":"2006","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0500","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1089\/jop.2018.0024","article-title":"Linear polyethylenimine-DNA nanoconstruct for corneal gene delivery","volume":"35","author":"Rodier","year":"2019","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0505","doi-asserted-by":"crossref","first-page":"107697","DOI":"10.1016\/j.exer.2019.107697","article-title":"In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization","volume":"185","author":"Luis de Red\u00edn","year":"2019","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0510","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4103\/0301-4738.36474","article-title":"Bevacizumab: off-label use in ophthalmology","volume":"55","author":"Grisanti","year":"2007","journal-title":"Indian J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0515","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00417-019-04569-8","article-title":"Off-label use of bevacizumab for wet age-related macular degeneration in Europe","volume":"258","author":"Bro","year":"2020","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0520","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.2147\/IJN.S195504","article-title":"Mesoporous silica nanoparticles as a delivery system for improving antiangiogenic therapy","volume":"14","author":"Sun","year":"2019","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0525","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1167\/iovs.03-1224","article-title":"In vivo gene delivery and visualization of corneal stromal cells using an adenoviral vector and Keratocyte-specific promoter","volume":"45","author":"Carlson","year":"2004","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0530","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1089\/hum.2015.167","article-title":"Efficient transduction of corneal stroma by adeno-associated viral serotype vectors for implications in gene therapy of corneal diseases","volume":"27","author":"Lu","year":"2016","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0535","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.omtn.2017.12.019","article-title":"Transcriptome profiling of neovascularized corneas reveals miR-204 as a multi-target biotherapy deliverable by rAAVs","volume":"10","author":"Lu","year":"2018","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0540","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035318","article-title":"Corneal transduction by intra-stromal injection of AAV vectors in vivo in the mouse and ex vivo in human explants","volume":"7","author":"Hippert","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0545","first-page":"751","article-title":"Inducible adeno-associated virus vector-delivered transgene expression in corneal endothelium","volume":"43","author":"Tsai","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0550","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/ICO.0000000000002182","article-title":"A fixed-depth microneedle enhances reproducibility and safety for corneal gene therapy","volume":"39","author":"Gilger","year":"2020","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172928","article-title":"Targeted AAV5-Smad7 gene therapy inhibits corneal scarring in vivo","volume":"12","author":"Gupta","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0560","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.bbrc.2007.07.114","article-title":"Inhibition of corneal neovascularization by recombinant adenovirus-mediated sFlk-1 expression","volume":"361","author":"Yu","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0565","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.addr.2013.11.008","article-title":"Understanding ultrasound induced sonoporation: definitions and underlying mechanisms","volume":"72","author":"Lentacker","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0570","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.1021\/acs.langmuir.8b03779","article-title":"The role of ultrasound-driven microbubble dynamics in drug delivery: from microbubble fundamentals to clinical translation","volume":"35","author":"Roovers","year":"2019","journal-title":"Langmuir."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0575","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/175889709X446507","article-title":"Microbubble compositions, properties and biomedical applications","volume":"1","author":"Sirsi","year":"2009","journal-title":"Bubble Sci. Eng. Technol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0580","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1167\/iovs.05-0889","article-title":"Gene transfer to corneal epithelium and keratocytes mediated by ultrasound with microbubbles","volume":"47","author":"Sonoda","year":"2006","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0585","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1006\/exer.2001.1117","article-title":"Targeted gene transfer to corneal stroma in vivo by electric pulses","volume":"74","author":"Oshima","year":"2002","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0590","doi-asserted-by":"crossref","first-page":"7376","DOI":"10.1167\/iovs.14-15257","article-title":"Intrastromal delivery of bevacizumab using microneedles to treat corneal neovascularization","volume":"55","author":"Kim","year":"2014","journal-title":"Investig. Opthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0595","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/s41467-018-06981-w","article-title":"Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery","volume":"9","author":"Than","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0600","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/lsm.20538","article-title":"Femtosecond laser corneal ablation threshold: dependence on tissue depth and laser pulse width","volume":"39","author":"Sun","year":"2007","journal-title":"Lasers Surg. Med."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0605","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/1120672119893291","article-title":"Femtosecond laser-assisted cataract surgery: a review","volume":"30","author":"Roberts","year":"2020","journal-title":"Eur. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0610","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3928\/1081597X-20131217-03","article-title":"Femtosecond laser versus manual clear corneal incision in cataract surgery","volume":"30","author":"Mastropasqua","year":"2014","journal-title":"J. Refract. Surg."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0620","doi-asserted-by":"crossref","first-page":"6981","DOI":"10.1021\/acs.nanolett.8b02896","article-title":"In vivo laser-mediated retinal ganglion cell optoporation using K V 1.1 conjugated gold nanoparticles","volume":"18","author":"Wilson","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0625","doi-asserted-by":"crossref","first-page":"8401","DOI":"10.1021\/acsnano.9b04050","article-title":"Photoablation of human vitreous opacities by light-induced vapor Nanobubbles","volume":"13","author":"Sauvage","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0630","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/418290a","article-title":"Targeted transfection by femtosecond laser","volume":"418","author":"Tirlapur","year":"2002","journal-title":"Nature."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0635","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1364\/BOE.4.001533","article-title":"Single-cell optoporation and transfection using femtosecond laser and optical tweezers","volume":"4","author":"Waleed","year":"2013","journal-title":"Biomed. Opt. Express."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0640","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1098\/rsif.2009.0463","article-title":"Single cell optical transfection","volume":"7","author":"Stevenson","year":"2010","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0645","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s13346-019-00638-x","article-title":"Mechanism of human nail poration by high-repetition-rate, femtosecond laser ablation","volume":"9","author":"Vanstone","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0650","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/jbio.201500120","article-title":"Femtosecond pulsed laser ablation to enhance drug delivery across the skin","volume":"9","author":"Garvie-Cook","year":"2016","journal-title":"J. Biophotonics"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0655","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/gt.2009.41","article-title":"Efficient lentiviral gene transfer into corneal stroma cells using a femtosecond laser","volume":"16","author":"Bemelmans","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0660","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3109\/08820538.2013.874482","article-title":"Femtosecond laser-assisted intra-corneal drug delivery","volume":"30","author":"Pallikaris","year":"2015","journal-title":"Semin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0665","first-page":"2211","article-title":"DL; Bennett, J; Alonso, L; Maguire, in vivo gene transfer into murine corneal endothelial and trabecular meshwork cells","volume":"36","author":"Budenz","year":"1995","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0670","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0161-6420(90)32575-7","article-title":"Comparison of limbal and conjunctival autograft transplantation in corneal surface reconstruction in rabbits","volume":"97","author":"Tsai","year":"1990","journal-title":"Ophthalmology."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0675","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.gt.3301574","article-title":"In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium","volume":"8","author":"Bainbridge","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0680","first-page":"3023","article-title":"Results of phase IIB SYLTAG clinical trial with bamosiran in patients with glaucoma","volume":"57","author":"Gonzales","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0685","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/mt.2013.216","article-title":"In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma","volume":"22","author":"Mart\u00ednez","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0690","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/nat.2019.0838","article-title":"Delivery of antisense oligonucleotides to the cornea","volume":"30","author":"Chau","year":"2020","journal-title":"Nucleic Acid Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0695","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/ICO.0000000000001664","article-title":"Predictive value of corneal donor demographics on endothelial cell density","volume":"37","author":"McGlumphy","year":"2018","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0700","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00003226-200005000-00022","article-title":"Adeno-associated and herpes simplex viruses as vectors for gene transfer to the corneal endothelium","volume":"19","author":"Hudde","year":"2000","journal-title":"Cornea."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0705","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1080\/02713680590927515","article-title":"Highly efficient ex vivo gene delivery into human corneal endothelial cells by recombinant adeno-associated virus","volume":"30","author":"Lai","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0710","article-title":"Viral vectors in gene therapy","volume":"6","author":"Lundstrom","year":"2018","journal-title":"Dis. (Basel, Switzerland)"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0715","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1089\/10430349950016889","article-title":"Target gene transfer of tissue plasminogen activator to cornea by electric pulse inhibits intracameral fibrin formation and corneal cloudiness","volume":"10","author":"Sakamoto","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0720","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/sj.gt.3300725","article-title":"Targeted gene transfer to corneal endothelium in vivo by electric pulse","volume":"5","author":"Oshima","year":"1998","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0725","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1046\/j.1442-9071.2000.00255.x","article-title":"Corneal endothelial cell nuclei are damaged after DNA transfer using a gene gun","volume":"28","author":"Klebe","year":"2000","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0730","first-page":"570","article-title":"FDA approves patisiran to treat hereditary transthyretin amyloidosis","volume":"14","author":"Wood","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0735","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1177\/153303460300200513","article-title":"Viral and non-viral vectors in gene therapy: technology development and clinical trials","volume":"2","author":"Lundstrom","year":"2003","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0740","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cclet.2017.01.021","article-title":"The in vitro and in vivo toxicity of gold nanoparticles","volume":"28","author":"Jia","year":"2017","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0745","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1038\/srep02499","article-title":"Bombarding cancer: biolistic delivery of therapeutics using porous Si carriers","volume":"3","author":"Zilony","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0750","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.biomaterials.2007.10.034","article-title":"The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery","volume":"29","author":"Lee","year":"2008","journal-title":"Biomaterials."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0755","series-title":"International Society for Optics and Photonics","first-page":"1029704","article-title":"Thermal techniques for reshaping the cornea","author":"Trembly","year":"2000"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0760","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2018.01.008","article-title":"Ocular delivery of proteins and peptides: challenges and novel formulation approaches","volume":"126","author":"Mandal","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.04.008_bb0765","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067888","article-title":"Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice","volume":"8","author":"Pearson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0770","series-title":"Dev. Ophthalmol","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000431195","article-title":"Ocular infection: endophthalmitis","author":"Schwartz","year":"2016"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0775","doi-asserted-by":"crossref","first-page":"6703","DOI":"10.1021\/acsnano.7b01023","article-title":"Super-cationic carbon quantum dots synthesized from spermidine as an eye drop formulation for topical treatment of bacterial keratitis","volume":"11","author":"Jian","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.04.008_bb0780","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1167\/iovs.14-15579","article-title":"A novel method using quantum dots for testing the barrier function of cultured epithelial cell sheets","volume":"56","author":"Duncan","year":"2015","journal-title":"Investig. Opthalmol. Vis. Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921001747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:02:58Z","timestamp":1759161778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921001747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":155,"alternative-id":["S0168365921001747"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Challenges and strategies for the delivery of biologics to the cornea","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}